Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:45:17 EST Sat 07 Feb 2026
Enter Symbol
or Name
USA
CA



Q:NYSE - - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NYSE - Qnot subscribed    Feb 0515 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-02-05 07:30U:NYSENews ReleaseBest of 2026: Cars.com Names Nissan Leaf Top Vehicle of the Year
2026-02-04 17:00U:NYSENews ReleaseCars Commerce and Del Grande Dealer Group Unveil New Solution for Dealers Built on Salesforce's Agentforce Automotive CRM
2026-02-02 07:30U:NYSENews ReleaseAccuTrade Launches a Single Solution for Smarter Appraisals and Inventory Management
2026-01-29 07:30U:NYSENews ReleaseCars.com Launches Powerful New Solutions, Helping Dealers Turn Smarter Technology into Real Profit
2026-01-29 06:45U:NYSENews ReleaseLockheed Martin and U.S. Department of War Sign Framework Agreement to Quadruple THAAD Interceptor Production Capacity
2026-01-28 01:31U:NYSENews ReleaseLockheed Martin's newest GPS satellite reaches orbit, strengthening warfighter connectivity
2026-01-22 09:00U:NYSENews ReleaseAdient announces breakthrough ModuTec innovation
2026-01-15 16:15U:NYSENews ReleaseNelnet Announces Retirement of President Tim Tewes
2026-01-06 07:45U:NYSENews ReleaseLockheed Martin and Department of War Advance Landmark Acquisition Transformation to Accelerate PAC-3(TM) MSE Production
2025-12-24 08:00U:NYSENews ReleaseWhite Mountains Announces Final Results of Its Tender Offer
2025-12-23 07:30U:NYSENews ReleaseCars Commerce Announces Inducement Awards Under NYSE Listing Rule 303A.08
2025-12-23 06:50U:NYSENews ReleaseGenesco Inc. to Present at 2026 ICR Conference on January 12, 2026
2025-12-12 08:45U:NYSENews ReleaseActinium Pharmaceuticals Presents New Preclinical Data Demonstrating Potent Anti-Tumor Activity of ATNM-400 Across Multiple Breast Cancer Subtypes Including Hormone Receptor-Positive, Triple-Negative, and Tamoxifen- and HER2 Therapy-Resistant Breast Cance
2025-11-03 08:30U:NYSENews ReleaseActinium Pharmaceuticals, Inc. to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference
2025-11-03 07:30U:NYSENews ReleaseUPS Acquires Andlauer Healthcare Group for $1.6 Billion, Accelerating Its Expansion as a Global Leader in Complex Healthcare Logistics
2025-10-24 08:30U:NYSENews ReleaseActinium Pharmaceuticals Presents New Data Demonstrating Potent and Durable Efficacy of ATNM-400, a First-in-Class Multi-Tumor Actinium-225 Radiotherapy, at the 32nd Annual Prostate Cancer Foundation Scientific Retreat
2025-10-13 12:10U:NYSENews ReleaseActinium Pharmaceuticals to Unveil the Multi-Tumor Potential of ATNM-400, a First-in-Class Actinium-225 Radiotherapy, with Data in Non-Small Cell Lung Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
2025-10-13 08:30U:NYSENews ReleaseActinium to Present ATNM-400 Preclinical Data Highlighting Durable Tumor Control and Ability to Overcome Resistance to Standard-of-Care Prostate Cancer Therapies at the 32nd Annual Prostate Cancer Foundation Scientific Retreat
2025-07-15 08:00U:NYSENews ReleaseBaidu and Uber Join Forces to Accelerate Autonomous Vehicle Deployment
2025-06-23 11:30U:NYSENews ReleaseActinium Highlights Expanded Data Set for ATNM-400 in Prostate Cancer Demonstrating Superior Efficacy to Enzalutamide and Ability to Overcome Resistance to ARPI Therapy and PSMA-Ac-225/Lu-177 Labelled Radiotherapy at the Society of Nuclear Medicine & Mole